Team:DTU-Denmark/SPL

From 2010.igem.org

(Difference between revisions)
Line 179: Line 179:
</td>
</td>
<td width="570 px">
<td width="570 px">
-
  <font color="#333333" face="arial" size="2.5">
 
<h1>Synthetic Promoter Library</h1>
<h1>Synthetic Promoter Library</h1>
<p align="justify"> Modulation of gene expression such as of cellular enzyme activities[1] as well as regulation of transcription are amongst some of the areas where Synthetic Promoter Libraries (SPLs) are currently being used. SPL provides an alternative method for gene regulation compared to the old methods, namely those of gene knockout as well as strong over expression, these two usually executed on the basis of apparent rate limiting steps[1].<br>
<p align="justify"> Modulation of gene expression such as of cellular enzyme activities[1] as well as regulation of transcription are amongst some of the areas where Synthetic Promoter Libraries (SPLs) are currently being used. SPL provides an alternative method for gene regulation compared to the old methods, namely those of gene knockout as well as strong over expression, these two usually executed on the basis of apparent rate limiting steps[1].<br>
Line 191: Line 190:
   
   
As previous studies indicate consensus regions outside of the -35 and -10 regions seem to contribute very little if anything at all in terms of altering promoter strengths, rather the spacer sequences surrounding the -35 and -10 regions seem to have the most significance[2]. This might be due to the three-dimensional structure that forms from the sequences that are arranged from the randomized spacer sequences[2].<br></p>
As previous studies indicate consensus regions outside of the -35 and -10 regions seem to contribute very little if anything at all in terms of altering promoter strengths, rather the spacer sequences surrounding the -35 and -10 regions seem to have the most significance[2]. This might be due to the three-dimensional structure that forms from the sequences that are arranged from the randomized spacer sequences[2].<br></p>
 +
 +
<table class="https://static.igem.org/mediawiki/2010/c/c8/SPL1.png" align="center">
 +
<caption align="bottom"><p align="justify"><b>Figure 1</b>: An SPL designed on the basis of randomizing both the spacer sequences surrounding the consensus regions (-35 and -10 regions) as well as randomizing two bases within each of the consensus regions is illustrated. N stands for 25% each of A, C, G and T, while S stands for 50% each of C and G, and W stands for 50% A and T.</p></caption>
 +
<tr><td><img src="https://static.igem.org/mediawiki/2010/c/c8/SPL1.png" ></td></tr>
 +
</table><br>
 +
 +
<table class="https://static.igem.org/mediawiki/2010/a/a6/SPL2.png" align="center">
 +
<caption align="bottom"><p align="justify"><b>Figure 2</b>: The linear BioBrick plasmid backbone with SPL inserted between the EcoRI and XbaI sites of the BioBrick prefix is illustrated.</p></caption>
 +
<tr><td><img src="https://static.igem.org/mediawiki/2010/a/a6/SPL2.png" ></td></tr>
 +
</table><br>
 +
 +
<table class="https://static.igem.org/mediawiki/2010/c/c7/SPL3.png" align="center">
 +
<caption align="bottom"><p align="justify"><b>Figure 3</b>: The primer binding sites on a BioBrick plasmid backbone as well as the final linear plasmid backbone that is generated by the PCR is illustrated.</p></caption>
 +
<tr><td><img src="https://static.igem.org/mediawiki/2010/c/c7/SPL3.png" ></td></tr>
 +
</table><br>
 +
 +
<table cellpadding="2" border="1px" cellspacing="0" align="center" width="300px">
 +
<caption><p align="justify"><b>Table 1</b>: illustrates the Tm of the SPL primers. IDT DNA oligo analyzer was used in order to calculate the Tm.</p></caption>
 +
<thead align="center">
 +
<td><b>Primer</b></td><td><b>Tm - &deg;C</b></td>
 +
</thead></tr>
 +
<font face="courier new">
 +
<tr>
 +
<td align="center"><i>I) Primer SPL Suffix-F</i></td><td align="center">62.1</td>
 +
</tr>
 +
<tr>
 +
<td align="center"><i>II) Primer SPL Prefix-R-01 </i></td><td align="center">59.8</td>
 +
</tr>
 +
<tr>
 +
<td align="center"><i>III) Primer SPL Prefix-R-02</i></td><td align="center">60</td>
 +
</tr>
 +
</font>
 +
</table>
 +
 +
<table cellpadding="2" border="1px" cellspacing="0" align="center">
 +
<caption><p align="justify"><b>Table 2</b></p></caption>
 +
<thead>
 +
<td align="left"><b>PCR substrates</b></td><td align="right"><b>Volumes - μL</b></td>
 +
</thead></tr>
 +
<tr>
 +
<td align="left">Total volume</td><td align="right">50</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Phusion Polymerase (0,02 U/μL)</td><td align="right">0.5</td>
 +
</tr>
 +
<tr>
 +
<td align="left">x5 Phusion HF buffer</td><td align="right">10</td>
 +
</tr>
 +
<tr>
 +
<td align="left">dNTP's (5μM)</td><td align="right">2</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Primer SPL Suffix-F (10μM)</td><td align="right">1.25</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Template - BioBrick plasmid backbone</td><td align="right">1</td>
 +
</tr>
 +
<tr>
 +
<td align="left">ddH2O</td><td align="right">33.5</td>
 +
</tr>
 +
</table>
 +
 +
<table cellpadding="2" border="1px" cellspacing="0" align="center">
 +
<caption><p align="justify"><b>Table 3</b></p></caption>
 +
<thead>
 +
<td align="left"><b>Cycle step</b></td><td align="right"><b>Temperature - ºC</b></td><td align="right"><b>Time</b></td><td align="right"><b>Cycles</b></td>
 +
</thead></tr>
 +
<tr>
 +
<td align="left">Initial denaturation</td><td align="right">98</td><td align="right">30 sec</td><td align="right">1</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Denaturation</td><td align="right">98</td><td align="right">10 sec</td><td align="right">-</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Annealing</td><td align="right">63*</td><td align="right">30 sec</td><td align="right">20-25</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Extension</td><td align="right">72</td><td align="right">30 sec / kb</td><td align="right">-</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Final extension</td><td align="right">72</td><td align="right">10 min</td><td align="right">1</td>
 +
</tr>
 +
<tr>
 +
<td align="left">Hold</td><td align="right">4</td><td align="right">forever</td><td align="right">1</td>
 +
</tr>
 +
</table>
 +
 +
 +
<table cellpadding="2" border="1px" cellspacing="0" align="center">
 +
<caption><p align="justify"><b>Table 4</b>: Prefix SPL primers that SHOULD be used depending on which BioBrick plamid backbone is selected for amplification is illustrated.</p></caption>
 +
<tr><thead>
 +
<td align="left"><b>BioBrick Plasmid Backbone</b></td><td align="right"><b>Primer II</b></td><td align="right"><b>Primer III</b></td><td align="right"><b>Sizes - bps</b></td>
 +
</thead></tr>
 +
<tr>
 +
<td align="left">pSB1A3</td><td align="center">+</td><td align="center">-</td><td align="right">2157</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB1AC3</td><td align="center">+</td><td align="center">-</td><td align="right">3055</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB1AK3</td><td align="center">+</td><td align="center">-</td><td align="right">3189</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB1AT3</td><td align="center">+</td><td align="center">-</td><td align="right">3446</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB1C3</td><td align="center">+</td><td align="center">-</td><td align="right">2072</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB1K3</td><td align="center">+</td><td align="center">-</td><td align="right">2206</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB1T3</td><td align="center">+</td><td align="center">-</td><td align="right">2463</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB2K3</td><td align="center">+</td><td align="center">-</td><td align="right">4425</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB3C5</td><td align="center">-</td><td align="center">+</td><td align="right">2738</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB3K5</td><td align="center">-</td><td align="center">+</td><td align="right">2936</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB3T5</td><td align="center">-</td><td align="center">+</td><td align="right">3252</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB4A5</td><td align="center">-</td><td align="center">+</td><td align="right">3395</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB4C5</td><td align="center">-</td><td align="center">+</td><td align="right">3221</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB4K5</td><td align="center">-</td><td align="center">+</td><td align="right">3419</td>
 +
</tr>
 +
<tr>
 +
<td align="left">pSB4T5</td><td align="center">-</td><td align="center">+</td><td align="right">3735</td>
 +
</tr>
 +
</table>
 +
</td>
</td>
<td width="163px" height="100%" valign="top">
<td width="163px" height="100%" valign="top">

Revision as of 23:27, 26 October 2010

Welcome to the DTU iGEM wiki!

Synthetic Promoter Library

Modulation of gene expression such as of cellular enzyme activities[1] as well as regulation of transcription are amongst some of the areas where Synthetic Promoter Libraries (SPLs) are currently being used. SPL provides an alternative method for gene regulation compared to the old methods, namely those of gene knockout as well as strong over expression, these two usually executed on the basis of apparent rate limiting steps[1].
When working with gene regulation, it is important to elucidate where expression levels are optimal of the given gene you are working with. Under these specifications it is essential to be able to have slight increments in expressional strength when attempting to optimize your gene.
This can be achieved by the usage of an SPL, where the variability in strengths can be achieved by either randomizing the spacer sequences, namely the 17 bases that reside between the -35 and -10 consensus regions, and or some of the bases within the consensus regions, being the -35 and -10 regions.

Figure 1: Illustration of SPL.


The spacer sequences that surround the consensus regions contribute significantly to the strengths of promoters[1]. In our design, we decided to both randomize the spacer sequences as well as randomize 2 bases in both of the consensus regions as seen in the provided diagram. N stands for 25% each of A, C, G and T, while R stands for 50% each of A and G, and W stands for 50% A and T. The point of randomizing both would be to obtain a promoter library that is not biased towards being all strong, by giving 2 bases within each of the consensus regions a 50% chance of being their original bases only 1/16 of all promoters will be strong, this being without taking into consideration the fraction of strong promoters obtainable from the randomized spacer sequences.
As previous studies indicate consensus regions outside of the -35 and -10 regions seem to contribute very little if anything at all in terms of altering promoter strengths, rather the spacer sequences surrounding the -35 and -10 regions seem to have the most significance[2]. This might be due to the three-dimensional structure that forms from the sequences that are arranged from the randomized spacer sequences[2].

Figure 1: An SPL designed on the basis of randomizing both the spacer sequences surrounding the consensus regions (-35 and -10 regions) as well as randomizing two bases within each of the consensus regions is illustrated. N stands for 25% each of A, C, G and T, while S stands for 50% each of C and G, and W stands for 50% A and T.


Figure 2: The linear BioBrick plasmid backbone with SPL inserted between the EcoRI and XbaI sites of the BioBrick prefix is illustrated.


Figure 3: The primer binding sites on a BioBrick plasmid backbone as well as the final linear plasmid backbone that is generated by the PCR is illustrated.


Table 1: illustrates the Tm of the SPL primers. IDT DNA oligo analyzer was used in order to calculate the Tm.

PrimerTm - °C
I) Primer SPL Suffix-F62.1
II) Primer SPL Prefix-R-01 59.8
III) Primer SPL Prefix-R-0260

Table 2

PCR substratesVolumes - μL
Total volume50
Phusion Polymerase (0,02 U/μL)0.5
x5 Phusion HF buffer10
dNTP's (5μM)2
Primer SPL Suffix-F (10μM)1.25
Template - BioBrick plasmid backbone1
ddH2O33.5

Table 3

Cycle stepTemperature - ºCTimeCycles
Initial denaturation9830 sec1
Denaturation9810 sec-
Annealing63*30 sec20-25
Extension7230 sec / kb-
Final extension7210 min1
Hold4forever1

Table 4: Prefix SPL primers that SHOULD be used depending on which BioBrick plamid backbone is selected for amplification is illustrated.

BioBrick Plasmid BackbonePrimer IIPrimer IIISizes - bps
pSB1A3+-2157
pSB1AC3+-3055
pSB1AK3+-3189
pSB1AT3+-3446
pSB1C3+-2072
pSB1K3+-2206
pSB1T3+-2463
pSB2K3+-4425
pSB3C5-+2738
pSB3K5-+2936
pSB3T5-+3252
pSB4A5-+3395
pSB4C5-+3221
pSB4K5-+3419
pSB4T5-+3735